BEIJING, Dec. 22, 2025 /PRNewswire/ -- When disruptive changes redefined market demand in the past days of 2025, Chinese baijiu producer Wuliangye convened recently its annual convention to seek consensus for navigating the changing liquor market. The event, the 29th Wuliangye 12•18 Annual Convention, caught global attention as a crowd of professionals gathered in Yibin City of Sichuan Prov...
BEIJING, Dec. 22, 2025 /PRNewswire/ -- When disruptive changes redefined market demand in the past days of 2025, Chinese baijiu producer Wuliangye convened recently its annual convention to seek consensus for navigating the changing liquor market. The event, the 29th Wuliangye 12•18 Annual Convention, caught global attention as a crowd of professionals gathered in Yibin City of Sichuan Prov...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- Shenzhen Media Group's "Telling China's Story: The 'Circle of Friends' of the Global Development Initiative" program has brought the "Gather in Shenzhen" Salon Series to Suva, Fiji, at the China Cultural Centre in Fiji, on Dec 8 and 9, bringing scholars and Gen Z together to discuss cooperation, opportunities, and APEC 2026 in Shen...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- Shenzhen Media Group's "Telling China's Story: The 'Circle of Friends' of the Global Development Initiative" program has brought the "Gather in Shenzhen" Salon Series to Suva, Fiji, at the China Cultural Centre in Fiji, on Dec 8 and 9, bringing scholars and Gen Z together to discuss cooperation, opportunities, and APEC 2026 in Shen...
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ -- Guardant Health Japan Corp. today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Guardant360® CDx on 23 October 2025 ...
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ -- Guardant Health Japan Corp. today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Guardant360® CDx on 23 October 2025 ...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- In an increasingly digital era, modern life and economic activities heavily rely on networks. Network stability directly impacts public 'digital well-being' and 'sense of social participation.' As the brain of the network, the core network must remain stable, since any service interruption can affect tens of millions of users, causing immeasurable soc...
SHENZHEN, China, Dec. 22, 2025 /PRNewswire/ -- In an increasingly digital era, modern life and economic activities heavily rely on networks. Network stability directly impacts public 'digital well-being' and 'sense of social participation.' As the brain of the network, the core network must remain stable, since any service interruption can affect tens of millions of users, causing immeasurable soc...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- Nan Yang Textile Group has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for the development of Elitech 360°, an advanced fabric technology designed to deliver optimal performance across a wide range of applications. Elitech 360° is a lightweight, high-performance fabric engineered with true...
SHANGHAI, Dec. 22, 2025 /PRNewswire/ -- Nan Yang Textile Group has been honoured at the International Innovation Awards (IIA) 2025, organized by Enterprise Asia, for the development of Elitech 360°, an advanced fabric technology designed to deliver optimal performance across a wide range of applications. Elitech 360° is a lightweight, high-performance fabric engineered with true...
Disclaimer: We are a tourism service provider that provides room booking services for Mercure Hotel Bonn Hardtberg We are not the official website of the hotel, please be aware.